SARS-CoV-2 Variants and COVID-19 in Bangladesh-Lessons Learned

被引:0
|
作者
Lytton, Simon D. [1 ]
Ghosh, Asish Kumar [2 ]
机构
[1] SeraDiaLogistics, D-81545 Munich, Germany
[2] Dhaka Med Coll Hosp, Dept Virol, Dhaka 1000, Bangladesh
来源
VIRUSES-BASEL | 2024年 / 16卷 / 07期
关键词
Bangladesh; COVID-19; SARS-CoV-2; variants; vaccination coverage; pandemic preparedness; IMMUNE ESCAPE; CHALLENGES;
D O I
10.3390/v16071077
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The coronavirus infectious disease-2019 (COVID-19) in Bangladesh is a paradigm for how one of the most densely populated countries in the world, with 1270 people per square kilometer, managed to cope with the COVID-19 pandemic under extraordinary circumstances. This review highlights the SARS-CoV-2 variants in Bangladesh and the timeline of their detection in the context of the global experience with the management of vaccination and natural SARS-CoV-2 infection. The motivation to overcome the COVID-19 vaccine dilemma and track Bangladeshi SARS-CoV-2 sub-variants underscores the potential for a low-income country to excel in international medical science, despite having stressed health care services and limited availability of resources for SARS-CoV-2 testing and gene sequencing.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] SARS-CoV-2 (COVID-19) by the numbers
    Bar-On, Yinon M.
    Flamholz, Avi
    Phillips, Rob
    Milo, Ron
    ELIFE, 2020, 9
  • [32] SARS-CoV-2, COVID-19, and the Eye
    Cunningham, Emmett T.
    Zierhut, Manfred
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (04) : 629 - 630
  • [33] Delirium and SARS-CoV-2/COVID-19
    von Arnim, C.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S14 - S14
  • [34] Characteristics of SARS-CoV-2 and COVID-19
    Hu, Ben
    Guo, Hua
    Zhou, Peng
    Shi, Zheng-Li
    NATURE REVIEWS MICROBIOLOGY, 2021, 19 (03) : 141 - 154
  • [35] SARS-CoV-2, COVID-19 and Neurodegeneration
    Toenges, Lars
    Klebe, Stephan
    BRAIN SCIENCES, 2022, 12 (07)
  • [36] SARS-CoV-2 and COVID-19 for the ophthalmologist
    Brandao-de-Resende, Camilo
    Diniz-Filho, Alberto
    de Almeida Brito, Fabiano
    Vasconcelos-Santos, Daniel Vitor
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 49 (01): : 70 - 80
  • [37] Analysis of SARS-CoV-2 Cases, COVID-19 Outcomes and Vaccinations, during the Different SARS-CoV-2 Variants in Greece
    Malli, Foteini
    Lampropoulos, Ioannis C.
    Perlepe, Garifallia
    Papagiannis, Dimitrios
    Gourgoulianis, Konstantinos I.
    VACCINES, 2023, 11 (01)
  • [38] Immunity to SARS-CoV-2: Lessons Learned
    Fergie, Jaime
    Srivastava, Amit
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [39] Genome Sequencing of Omicron Variants of SARS-CoV-2 Circulating in Bangladesh during the Third Wave of the COVID-19 Pandemic
    Jahan, Munira
    Nasif, M. Abdullah Omar
    Rahmat, Raad
    Ul Islam, S. M. Rashed
    Munshi, Saif Ullah
    Ahmed, M. Sharfuddin
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2022, 11 (07):
  • [40] Genetic determinants of SARS-CoV-2 and the clinical outcome of COVID-19 in Southern Bangladesh
    Hasan, Md. Mahbub
    Saha, Chayan Kumar
    Mehedi, H. M. Hamidullah
    Chakma, Kallyan
    Salauddin, Asma
    Hossain, Md. Shakhawat
    Sharmen, Farjana
    Islam, S. M. Rafiqul
    Tanni, Afroza Akter
    Yasmin, Farhana
    Akash, Al-Shahriar
    Hossain, Mohammad Enayet
    Miah, Mojnu
    Biswas, Sanjoy Kanti
    Sultana, Nahid
    Mannan, Adnan
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (02)